Search

Your search keyword '"Bourdin S"' showing total 137 results
Start Over Author "Bourdin S"
137 results on '"Bourdin S"'

8. Dossier « L’économie circulaire : modes de gouvernance et développement territorial » – « La méthanisation, oui, mais pas chez moi ! » Une analyse du discours des acteurs dans la presse quotidienne régionale★

Author

Bourdin Sébastien, Jeanne Philippe, and Raulin François

Subjects
analyse de discours, conflits, développement durable, méthanisation, territoire, Science, Social Sciences
Abstract

La transition énergétique est aujourd’hui considérée par les institutions nationales, européennes et internationales comme incontournable. Cependant, le déploiement des énergies renouvelables telles que la méthanisation peut être source de conflit. À partir d’un corpus d’articles issus de la presse quotidienne régionale, nous avons réalisé une analyse lexicométrique du discours des acteurs de la méthanisation afin de mieux comprendre les oppositions locales et d’identifier les leviers pour faciliter l’acceptation sociale. L’étude analyse les craintes et les principales méfiances liées à la méthanisation. Par conséquent, la territorialisation des projets d’unités de méthanisation nécessite de trouver de nouveaux compromis sociaux en conciliant l’intérêt général (la transition énergétique) et les intérêts singuliers (relatifs aux externalités des énergies vertes déployées).

Published
2020
Full Text
View/download PDF

10. Chromosome aberrations after radiotherapy in patients treated for non Hodgkin's lymphoma

Author

Ma, Mahé, Mj, André, Moyon E, Le Mevel A, Soubeyran P, Hamidou M, Noel Milpied, Bourdin S, Jc, Cuillière, and Jf, Chatal

Subjects
Chromosome Aberrations, Radiotherapy, Case-Control Studies, Humans, Lymphocytes, Lymphoma, Follicular
Abstract

Chromosome aberrations were evaluated in the lymphocytes of 30 patients who had undergone radiotherapy several years before for non-Hodgkin's lymphoma. Twelve had received 20 Gy over the entire abdomen (group I), 12 wholebody irradiation at 1.5 Gy (group II) and 6 wholebody irradiation at 15 Gy (group III). Unirradiated patients seen for cytogenetic analysis during the same period served as controls. Overall results for the irradiated population were 13/27 (48%) evaluable patients with chromosome aberrations and 50/710 (7%) abnormal cells for a total of 73 aberrations (unstable: 35, stable: 38). The frequency of aberrations was statistically higher in group I (12% of cells) than in groups II (3.5%, p0.0001) and III (2.5%, p0.0002). Differences in irradiation dose and volume may account for the variations between groups.

Published
1997

15. RCMI avec guidage par l’image de rattrapage et TEP à la 18F choline de patients en situation de récidive biochimique après traitement initial radical de cancer prostatique : résultats préliminaires

Author

Dewas, S., primary, Cochet, A., additional, Talbot, J.-N., additional, Supiot, S., additional, Brunotte, F., additional, Rousseau, C., additional, Truc, G., additional, Bourdin, S., additional, Maingon, P., additional, and Créhange, G., additional

Published
2010
Full Text
View/download PDF

26. Phase III multicenter randomized study of concurrent twice-a-day radiotherapy with and without cisplatin-5FU (BiRCF) in unresectable pharyngeal carcinoma. Results at 18 months (FNCLCC-GORTEC)

Author

Bensadoun, R. J., primary, Dassonville, O., additional, Ramaioli, A., additional, Magné, N., additional, Benezery, K., additional, Marcy, P. Y., additional, Poissonnet, G., additional, Lemanski, C., additional, Bourdin, S., additional, and Tortochaux, J., additional

Published
2004
Full Text
View/download PDF

28. A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma

Author

Mornex, F, primary, Thomas, L, additional, Mohr, P, additional, Hauschild, A, additional, Delaunay, M M, additional, Lesimple, T, additional, Tilgen, W, additional, Bui, B N, additional, Guillot, B, additional, Ulrich, J, additional, Bourdin, S, additional, Mousseau, M, additional, Cupissol, D, additional, Bonneterre, M E, additional, de Gislain, C, additional, Bensadoun, R J, additional, and Clavel, M, additional

Published
2003
Full Text
View/download PDF

29. Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas... presented at the 31st Meeting of the American Society of Clinical Oncology, Los Angeles, CA, May 19-23, 1995.

Author

Beauvillain C, Mahe M, Bourdin S, Peuvrel P, Bergerot P, Riviere A, Vignoud J, Deraucourt D, Wesoluch M, Beauvillain, C, Mahé, M, Bourdin, S, Peuvrel, P, Bergerot, P, Rivière, A, Vignoud, J, Deraucourt, D, and Wesoluch, M

Abstract

After neoadjuvant chemotherapy, a routine conservative approach followed by salvage surgery was evaluated in terms of local control and survival in cases of advanced potentially resectable hypopharyngeal carcinoma. Between 1985 and 1989, 92 patients with T3 or T4-NO,N3 operable squamous cell hypopharyngeal carcinomas received three courses of neoadjuvant chemotherapy every 2 weeks involving a combination of cisplatin, 100 mg/m2, on day 1 and fluorouracil, 1 g/m2, on days 2 to 5, followed by total laryngopharyngectomy plus postoperative radiotherapy in 47 patients (arm A) or radiotherapy alone in 45 patients (arm B). Randomization was always performed prior to chemotherapy. The response rates of tumor and node to chemotherapy were, respectively, 67% in arm A versus 79% in arm B (P > 0.05) and 54% in arm A versus 73% in arm B (P > 0.05). Grade III or IV toxicity was similar, affecting 15% of patients and 7% of cycles in arm A versus 16% of patients and 6% of cycles in arm B. After a mean follow-up of 92 months, survival was statistically better (P = 0.04) in arm A (5-year overall survival, 37%; median survival, 40 months) than in arm B (19% and 20 months) because of a better local control rate (63% versus 39%; P < 0.01). Better results were obtained for mutilant surgery in terms of local control and overall survival, regardless of response to neoadjuvant chemotherapy. [ABSTRACT FROM AUTHOR]

Published
1997

30. Very accelerated versus conventional radiotherapy in HNSCC: Results of the GORTEC 94-02 randomized trial

Author

Bourhis, J, primary, Lapeyre, M, additional, Tortochaux, J, additional, Rives, M, additional, Bourdin, S, additional, Benassi, T, additional, Dubois, J.B, additional, Lesaunier, F, additional, Geoffrois, L, additional, Verrelle, P, additional, Daly-Schveitzer, N, additional, Bardet, E, additional, Wibault, P, additional, Eschwege, F, additional, and Benhamou, E, additional

Published
2000
Full Text
View/download PDF

33. 111 Concurrent twice-a-day continuous radiotherapy and cisplatin-5fluorouracil chemotherapy (BIRCF) in locally advanced unresectable pharyngeal squamous-cell carcinoma—Final results of a French multicentric phase II study (clinical and pharmacological data)

Author

Bensadoun, RJ, primary, Dassonville, O, additional, Schneider, M, additional, Milano, G, additional, Chauvel, P, additional, Bourdin, S, additional, Prevost, B, additional, Coche-Dequeant, B, additional, Poissonnet, G, additional, Laudoyer, Y, additional, Vallicioni, J, additional, Santini, J, additional, Marcy, PY, additional, and Demard, F, additional

Published
1997
Full Text
View/download PDF

35. Radiothérapie bifractionnée continue à 80,4 Gy et chimiothérapie par CDDP-5 FU concomitante (BIRCF) dans les carcinomes épidermoïdes localement avancés non résécables de l'oropharynx et de l'hypopharynx: résultats de l'essai de phase II de la FNCLCC, et mise en place d'un essai multicentrique randomisé de phase III: BIRCF versus RT bifractionnée exclusive

Author

Bensadoun, RJ, primary, Dassonville, O, additional, Chauvel, P, additional, Schneider, M, additional, Etienne, MC, additional, Milano, G, additional, Courdi, A, additional, Pignol, JP, additional, Lagrange, JL, additional, Teissier, E, additional, Marcy, PY, additional, Bourdin, S, additional, Prévost, B, additional, Coche-Dequeant, B, additional, and Demard, F, additional

Published
1996
Full Text
View/download PDF

36. 151Can pilocarpine hydrochloride relieve xerostomia regardless of the destruction of major salivary glands? A prospective French cooperative study

Author

Horiot, J.C., primary, Lipinski, F., additional, Schraub, S., additional, Maylin, C., additional, Bensadoun, R.J., additional, Gérard, J.P., additional, Bolla, M., additional, Coscas, Y., additional, Baillet, F., additional, Coche-Dequéant, B., additional, Urbajtel, M., additional, Montbarbon, X., additional, Bourdin, S., additional, Wibault, P., additional, Pene, F., additional, Alfonsi, M., additional, Calais, G., additional, Desprez, P., additional, Favre, A., additional, Lapeyre, M., additional, Vinke, J., additional, Labart, M., additional, and Savary, J., additional

Published
1996
Full Text
View/download PDF

37. 2027 Continuous twice-a-day radiotherapy and concomitant CDDP-5fu chemotherapy (BiRCF) for the treatment of locallyadvanced inoperable pharyngeal carcinomas: Final results of a multicentric phase II study (FNCLCC)

Author

Bensadoun, R.J., primary, Chauvel, P., additional, Dassonville, O., additional, Laudoyer, Y., additional, Bourdin, S., additional, Prevost, B., additional, Resbeut, M., additional, Schneider, M., additional, and Demard, F., additional

Published
1995
Full Text
View/download PDF

39. Combined bifractionated radiotherapy and CDDP-5FU chemotherapy (BIRCF) in locally advanced inoperable pharyngeal carcinomas — a phase II study

Author

Bensadoun, RJ, primary, Chauvel, P, additional, Bourdin, S, additional, Peuvrel, P, additional, Prevost, B, additional, Resbeut, M, additional, Schneider, M, additional, Thyss, A, additional, Dassonville, O, additional, Demard, F, additional, Vallicioni, J, additional, Lefebvre, JC, additional, and Pech-Gourd, A, additional

Published
1993
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results